Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing scheme

Clinical Microbiology and Infection

Volumn 14, Issue 7, 2008, Pages 708-715

  Wisplinghoff, H ^a   Hippler, C ^a   Bartual, S G ^b   Haefs, C ^a   Stefanik, D ^a   Higgins, P G ^a   Seifert, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Acinetobacter baumannii; Acinetobacter genomic species 13TU; Epidemiology; Multilocus sequence typing; Pulsed field gel electrophoresis; Random amplified polymorphic DNA; Typing

Indexed keywords

CHAPERONIN; CITRATE SYNTHASE; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GLUCOSE 6 PHOSPHATE ISOMERASE; GLUCOSE DEHYDROGENASE; GLUCOSE DEHYDROGENASE B; RAC A PROTEIN; RAC PROTEIN; RNA POLYMERASE;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLONAL SPECIES; CONTROLLED STUDY; EPIDEMIC; EUROPE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC DATABASE; GENOME ANALYSIS; HUMAN; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; UNITED STATES;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

EID: 45249096489     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02010.x     Document Type: Article

References (36)

1. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: A cohort study. Clin Infect Dis 2001; 33: 939-946.
2. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9: 148-165.
3. Brisse S, Milatovic D, Fluit AC. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol 2000; 38: 3636-3645.
4. Dijkshoorn L, Aucken H, Gerner-Smidt P et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996; 34: 1519-1525.
5. Landman D, Quale JM, Mayorga D et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: The preantibiotic era has returned. Arch Intern Med 2002; 162: 1515-1520.
6. Seifert H, Schulze A, Baginski R et al. Comparison of four different methods for epidemiologic typing of Acinetobacter baumannii. J Clin Microbiol 1994; 32: 1816-1819.
7. Kraniotaki E, Manganelli R, Platsouka E et al. Molecular investigation of an outbreak of multidrug-resistant Acinetobacter baumannii, with characterisation of class.1 integrons. Int J Antimicrob Agents 2006; 28: 193-199.
8. Manikal VM, Landman D, Saurina G et al. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000; 31: 101-106.
9. Jones ME, Draghi DC, Thornsberry C et al. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004; 3: 14.
10. Karlowsky JA, Draghi DC, Jones ME et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003; 47: 1681-1688.
11. Bogaerts P, Naas T, Wybo I et al. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. J Clin Microbiol 2006; 44: 4189-4192.
12. Coelho JM, Turton JF, Kaufmann ME et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol 2006; 44: 3623-3627.
13. Gerner-Smidt P. Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. J Clin Microbiol 1992; 30: 2680-2685.
14. Horrevorts A, Bergman K, Kollee L et al. Clinical and epidemiological investigations of Acinetobacter genomospecies 3 in a neonatal intensive care unit. J Clin Microbiol 2002; 33: 1567-1572.
15. Seifert H, Gerner-Smidt P. Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J Clin Microbiol 1995; 33: 1402-1407.
16. Grundmann HJ, Towner KJ, Dijkshoorn L et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 1997; 35: 3071-3077.
17. Yoo JH, Choi JH, Shin WS et al. Application of infrequent-restriction-site PCR to clinical isolates of Acinetobacter baumannii and Serratia marcescens. J Clin Microbiol 1999; 37: 3108-3112.
18. Maiden MC, Bygraves JA, Feil E et al. Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998; 95: 3140-3145.
19. Feil EJ, Smith JM, Enright MC et al. Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data. Genetics 2000; 154: 1439-1450.
20. Enright MC, Day NP, Davies CE et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 1008-1015.
21. Wisplinghoff H, Rosato AE, Enright MC et al. Related clones containing SCCmec type.IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother 2003; 47: 3574-3579.
22. Homan WL, Tribe D, Poznanski S et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol 2002; 40: 1963-1971.
23. Bartual SG, Seifert H, Hippler C et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4382-4390.
24. Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
25. Wisplinghoff H, Edmond MB, Pfaller MA et al. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility. Clin Infect Dis 2000; 31: 690-697.
26. Juni E. Interspecies transformation of Acinetobacter: Genetic evidence for a ubiquitous genus. J Bacteriol 1972; 112: 917-931.
27. Bouvet PJM, Grimont PAD. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987; 138: 569-578.
28. Vaneechoutte M, Elaichouni A, Maquelin K et al. Comparison of arbitrarily primed polymerase chain reaction and cell envelope protein electrophoresis for analysis of Acinetobacter baumannii and A. junii outbreaks. Res Microbiol 1995; 146: 457-465.
29. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
30. Jolley KA, Feil EJ, Chan MS et al. Sequence type analysis and recombinational tests (START). Bioinformatics 2001; 17: 1230-1231.
31. Bou G, Cervero G, Dominguez MA et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases. J Clin Microbiol 2000; 38: 3299-3305.
32. Wisplinghoff H, Ewertz B, Wisplinghoff S et al. Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany from 1984-1998. J Clin Microbiol 2005; 43: 5445-5451.
33. Ecker JA, Massire C, Hall TA et al. Identification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry. J Clin Microbiol 2006; 44: 2921-2932.
34. Vila J, Ruiz J, Navia M et al. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol 1999; 37: 758-761.
35. Naas T, Coignard B, Carbonne A et al. VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006; 12: 1214-1222.
36. van Dessel H, Dijkshoorn L, van der Reijden T et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004; 155: 105-112.